Navigation Links
Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
Date:10/6/2010

NEW YORK, Oct. 6 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) (the "Company"), today announced that it intends, subject to market conditions, to offer 4,500,000 shares of its common stock pursuant to an underwriting agreement with Citi acting as the sole bookrunner.  

The Company expects to use the net proceeds from the sale of the shares for general corporate purposes.  Closing of the offering is expected to occur on or about October 11, 2010, subject to customary closing conditions.  In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional 675,000 shares of common stock to cover over-allotments, if any.

The offering is being made pursuant to an effective shelf registration statement.  Before you invest, you should read the base prospectus in such shelf registration statement, the prospectus supplement, when available, and other documents the Company has filed with the Securities and Exchange Commission for more complete information about the Company and this offering.  The offering may be made only by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained by sending a request to the offices of Citi at Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220, telephone number (800) 831-9146.  Alternatively, you may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the securities, nor shall there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.  

About Regeneron
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
2. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
3. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
4. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
5. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Reports Third Quarter 2009 Financial and Operating Results
8. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
9. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
10. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
11. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... 2011 Sanofi (EURONEXT: SAN and NYSE: ... of its dermatology business, Dermik, to Valeant Pharmaceuticals ... cash consideration of US $425 million. Valeant is ... dermatology therapeutic areas, based in Mississauga, Ontario, Canada. ...
... Pa., July 11, 2011 In a study sponsored ... company, scientists from the University of Massachusetts, Amherst presented ... was active against lice eggs from permethrin resistant head ... on Saturday, July 9, 2011 at the 37th ...
Cached Medicine Technology:Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 2Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 3Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 4Topaz Pharmaceuticals' Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs 2
(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through ... will feature “Hot Dog Wednesdays" and Ice Cold Slushies at ... hot dogs and all the fixin's to donors on Wednesdays. ... the summer. “Donors are our lifeline. The summer months are ... blood supply. This is a small way for us ...
(Date:5/19/2013)... FL (PRWEB) May 19, 2013 The ... the website YazSideEffects.com in a concerted effort to connect ... the combination birth control drugs Yaz, Yasmin & Ocella ... a wealth of information on the notorious birth control ... against Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella ...
(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...
(Date:5/18/2013)... Illuminations is proud to present the Inner ... will take place over the course of four days, on ... Saturday, June 8, 2013. , Inner Child Therapy is concerned ... the attitudes, patterns and coping mechanisms that create the behavior ... to live a more integrated and balanced life style, to ...
Breaking Medicine News(10 mins):Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:Illuminations Brings World Renowned Therapist to the Middle East 2
... a significant problem for American children, who miss about 1.6 million ... A new study published in the July issue of the journal ... of children have never seen a dentist and that disparities exist ... the duration between dental care visits. The study, ...
... Stone ... Showing a 9.9 Year Survival Rate. ,Success of Less Invasive Procedures for Knee ... ... 2010 -- Biologic knee repair, rather than bionic (artificial) replacement, may slow the progression ...
... -- Cosmetic contact lenses that give wearers an exaggerated ... among teenagers and young adults," the American Academy of ... "circle" lens extends beyond the iris and, in doing ... the young increased recently after pop star Lady Gaga ...
... ... the quality of family’s lives by providing the healthiest and most practical pool care ... and ultimately “greener” in nature. Pool Joe is determined to offer and encourage their ... , ...
... July 2010: Frontiers in Cardiovascular Biology ( ... organised by the Council on Basic Cardiovascular ... Society of Cardiology (ESC), is being held ... new European platform for the exchange of ...
... , ... Foundation Announced Today Construction of a State-of-the-Art Hospital in Rural Kenya. Founded by ... a Patient. The Foundation,s Investment Management Approach to African Philanthropy is a Departure ... ...
Cached Medicine News:Health News:1 in 4 Californian children have never seen a dentist, study finds 2Health News:Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 2Health News:Lady Gaga-Inspired Lens Fad Draws Warning From Eye Docs 2Health News:Los Angeles Pool Service Company Pool Joe is Going Organic using Eco-Safe Pool Products 2Health News:Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany 2Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 2Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 3
... Plus IgM Controls identify trends ... your ToRCH IgM immunoassay testing ... results. Liquichek ToRCH Plus IgM ... to Liquichek ToRCH Plus Controls ...
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
... are liquid controls designed to ... procedures that detect Chlamydia trachomatis ... are specimen specific, they can ... or endocervical/urethral swabs throughout the ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Medicine Products: